Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies

Nov. 11, 2021

New cystic fibrosis mouse models allow testing of therapies for W1282X nonsense mutations

Nov. 10, 2021

CG-223 demonstrates antifibrotic effects in a murine model of pulmonary fibrosis

Nov. 9, 2021

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

Nov. 9, 2021

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Nov. 8, 2021

New JAK inhibitors patented by Gossamer Bio

Nov. 8, 2021

Researchers develop a cystic fibrosis-related diabetes murine model

Nov. 8, 2021

F508del and G542X cystic fibrosis sheep models exhibit severe phenotype

Nov. 5, 2021

BPN-15477 corrects splicing defect caused by the c.2988G>A variant in CFTR

Nov. 5, 2021

ELD-607 reduces pulmonary inflammation and lung damage in vivo

Nov. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...